CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase

Communications in Clinical Cytometry

Volumn 38, Issue 3, 1999, Pages 102-105

  Bell, Philip B ^a   Rooney, Nicholas ^a   Bosanquet, Andrew G ^a,b  

^a UNIVERSITY OF BATH   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

CD23; CD5; CD79a; Chronic lymphocytic leukemia (CLL); Flow cytometry; Immunophenotype; Mantle cell lymphoma (MCL); Monoclonal antibody (mAb)

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD79; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MIDDLE AGED; RECEPTORS, ANTIGEN, B-CELL;

EID: 0033564607     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990615)38:3<102::AID-CYTO2>3.0.CO;2-0     Document Type: Article

References (12)

1. Grupp SA, Mitchell RN, Schreiber KL, McKean DJ, Abbas AK. Molecular mechanisms that control expression of the B lymphocyte antigen receptor complex. J Exp Med 1995;181:161-168.
2. Nakamura T, Sekar MC, Kubagawa H, Cooper MD. Signal transduction in human B cells initiated via Igβ ligation. Int Immunol 1993;5:1309-1315.
3. Reth M. The B-cell antigen receptor complex and co-receptors. Immunol Today 1995;16:310-313.
4. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, Jaffe E, Ralfkiaer E, Dallenbach F, Stein H, Pileri S, Gatter KC. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995;86:1453-1459.
5. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
6. Bosanquet AG, Bell PB. Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology. Leuk Res 1996;20:143-153.
7. Zomas AP, Matutes E, Morilla R, Owusu-Ankomah K, Seon BK, Catovsky D. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 1996;10:1966-1970.
8. Thompson AA, Talley JA, Do HN, Kagan HL, Kunkel L, Berenson J, Cooper MD, Saxon A, Wall R. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 1997;90:1387-1394.
9. Hashimoto S, Chiorazzi N, Gregersen PK. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol 1995;32:651-659.
10. Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VVVS, Schluger A, Chaganti RSK. p53 Overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995;86:2892-2899.
11. Molica S, De Rossi G, Luciani M, Levato D. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Haematologica 1995;80:176-193.
12. Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 1996;105:451-457